Mukka Proteins received in-principle approval from the National Stock Exchange and BSE for a preferential issue of convertible warrants. The transaction targets non-promoter investors.

The company secured regulatory clearance on August 28, 2026, for the allotment of 2,00,00,000 convertible warrants. Each warrant carries a face value of Re. 1 and an issue price of ₹23.50. The total potential raise stands at approximately ₹47 crore upon full subscription.

Deal Structure

The exchange approvals permit Mukka Proteins to proceed with the issue subject to compliance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and the Companies Act, 2013. The warrants are convertible into equity shares on a one-to-one basis.

Regulatory Conditions

Both exchanges mandated strict adherence to internal controls regarding trading by allottees. The company must obtain undertakings confirming that allottees will not engage in intra-day trading or sell the scrip before the allotment date. Failure to comply with these provisions under Chapter V of the SEBI ICDR Regulations could impact the listing of the shares.

Mukka Proteins is required to file a listing application within twenty days of allotment. The company must also pay applicable fees and submit necessary documents to both exchanges.

What the Numbers Show

The issuance of convertible warrants rather than direct equity suggests a strategic approach to capital raising that may offer investors upside participation while deferring immediate dilution until conversion. The fixed issue price of ₹23.50 sets a clear valuation benchmark for this capital infusion.

Mukka Proteins Limited dispatched its 16th Annual General Meeting (AGM) notice and the Annual Report for the financial year 2025-26 to shareholders on August 18, 2026. This communication follows an earlier intimation issued to the National Stock Exchange of India Limited and BSE Limited on August 14, 2026, regarding the scheduling of the event. The company also published newspaper advertisements in Business Standard and Vijaya Karnataka on August 19, 2026, intimating shareholders of the meeting details.

The 16th AGM is scheduled to be held on Thursday, September 10, 2026, at 3:00 pm (IST). In compliance with the Companies Act, 2013, and relevant circulars from the Ministry of Corporate Affairs and the Securities and Exchange Board of India, the meeting will be conducted exclusively through Video Conferencing or Other Audio-Visual Means (VC/OAVM). The deemed venue for the meeting is the Company’s registered office in Mangaluru.

E-Voting and Record Date

The Company has provided an e-voting facility to its members to exercise their right to vote on the resolutions proposed in the AGM notice. The cut-off date for determining eligibility to vote is Thursday, September 3, 2026. Only members whose names appear in the Register of Members or list of beneficiaries received from Depositories as on this date will be eligible to participate. Central Depository Services (India) Limited (CDSL) has been appointed to provide VC/OAVM services along with the e-voting facility.

The remote e-voting period is scheduled as follows:

Members who have not cast their votes via remote e-voting will be able to vote during the AGM through the VC/OAVM facility. Those who have already voted remotely may join the meeting but will not be entitled to vote again. Once a vote is cast, it cannot be changed subsequently.

Business Agenda

The AGM notice outlines both ordinary and special business items for shareholder approval. Key agenda items include:

• Adoption of Audited Standalone and Consolidated Financial Statements for FY26.
• Re-appointment of directors retiring by rotation: Mr. Kalandan Mohammad Arif and Mrs. Umaiyya Banu.
• Re-appointment of Non-Executive Independent Directors: Mr. Karkala Shankar Balachandra Rao, Mr. Hamad Bava, and Mr. Narendra Surendra Kamath.
• Re-appointment of Key Managerial Personnel: Mr. Kalandan Mohammed Haris (MD & CEO), Mr. Kalandan Mohammed Althaf (WTD & CFO), and Mr. Kalandan Mohammad Arif (WTD & COO).
• Approval of increased borrowing limits up to ₹1,000 crore under Section 180(1)(c) of the Companies Act, 2013.
• Approval of creation of mortgage/charge on assets up to ₹1,000 crore under Section 180(1)(a).
• Approval of material related party transactions with Atlantic Marine Products Private Limited, Progress Frozen and Fish Sterilizetion, Ullal Fish Meal and Oil Company, and Mangalore Fish Meal and Oil Company.

The Annual Report and AGM Notice are also available on the Company’s website at https://mukkaproteins.com/annual-report/ and on the websites of BSE Limited, NSE India, and CDSL. The announcement was signed by Mehaboobsab Mahmadgous Chalyal, Company Secretary and Compliance Officer.